Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 29.11
-3.64 %
$ 3.6 B
Market Cap
-6.8
P/E
Price Target
Average
29.17%
Revenue Forecast
Estimate
26.11%
EBIT
Estimate
--19.27%
Net Income
Estimate
12.99%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Guardant Health, Inc.
Wall Street analysts predict an average 1-year price target for GH of $37.6 , with forecasts ranging from a low of $28 to a high of $50 .
GH Lowest Price Target
Wall Street Target
28 USD
-3.81%
GH Average Price Target
Wall Street Target
37.6 USD
29.17%
GH Highest Price Target
Wall Street Target
50 USD
71.76%
REVENUE FORECAST
Revenue Forecast Chart GH
EBIT FORECAST
EBIT Forecast Chart GH
NET INCOME FORECAST
Net Income Chart GH